Pyxis Oncology follow-on prices 39.7 mln shares and warrants for $110 mln gross
Pyxis Oncology priced a follow-on: ~39.7 mln shares and pre-funded warrants at $2.90 each for $110 mln gross proceeds, plus ~49.3 mln warrants at $3.50 exercise price for additional $172.6 mln if fully exercised.
90 on Tues, but had rallied 152% YTD * 9 of 10 analysts rate the stock "strong buy" or "buy", 1 "hold"; median PT $7, per LSEG (Lance Tupper is a Reuters market analyst. com 1-646-279-6380)